Influence of infliximab therapy on radiographic progression in patients with ankylosing spondylitis - Results after 4 years of treatment.

被引：0
|
作者：
Baraliakos, X
Listing, J
Brandt, J
Rudwaleit, M
Sieper, J
Braun, K
机构：
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] German Rheumatism Res Ctr, Berlin, Germany
[3] Charite, Berlin, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S631 / S631
页数：1
相关论文
共 50 条
  • [41] SECUKINUMAB DEMONSTRATES LOW RADIOGRAPHIC PROGRESSION AND SUSTAINED EFFICACY THROUGH 4 YEARS IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS
    Baraliakos, X.
    Braun, J.
    Deodhar, A.
    Poddubny, D.
    Emery, P.
    Delicha, E. M.
    Talloczy, Z.
    Porter, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 997 - 998
  • [42] SPINAL RADIOGRAPHIC PROGRESSION DURING 6 YEARS OF TNF-ALPHA BLOCKING THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS FROM THE GLAS COHORT
    Maas, F.
    Spoorenberg, A.
    Brouwer, E.
    Bos, R.
    Efde, M.
    Chaudhry, R. N.
    Veeger, N. J.
    Bootsma, H.
    van der Veer, E.
    Arends, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 716 - 717
  • [43] Validation Of The Ankylosing Spondylitis Disease Activity Score and Effectiveness Of Infliximab In The Treatment Of Ankylosing Spondylitis Over 4 Years: The Canadian Experience
    Rahman, Proton
    Choquette, Denis
    Khraishi, Majed M.
    Bensen, William G.
    Shaikh, Saeed A.
    Sholter, Dalton E.
    Sheriff, Maqbool K.
    Rampakakis, Emmanouil
    Sampalis, John S.
    Nantel, Francois
    Otawa, Susan M.
    Lehman, Allen J.
    Shawi, May
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S658 - S659
  • [44] Erratum to: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
    Xenofon Baraliakos
    Joachim Listing
    Jan Brandt
    Angela Zink
    Rieke Alten
    Gerd Burmester
    Erika Gromnica-Ihle
    Herbert Kellner
    Matthias Schneider
    Helmut Sörensen
    Hennig Zeidler
    Martin Rudwaleit
    Joachim Sieper
    Juergen Braun
    Arthritis Research & Therapy, 7
  • [45] Clinical response to withdrawal of anti-TNF therapy in patients with ankylosing spondylitis (AS) after 3 years of continous treatment with infliximab.
    Baraliakos, X
    Brandt, J
    Listing, J
    Rudwaleit, M
    Sieper, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S216 - S217
  • [46] Sustained reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab
    Braun, J.
    Landewe, R.
    Hermann, K. G.
    Deodhar, A.
    Baker, D.
    Han, J.
    Xu, W.
    Williamson, P.
    Van der Heijde, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 64 - 64
  • [47] Sustained reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab
    Braun, J.
    Landewe, R.
    Hermann, K. G.
    Deodhar, A.
    Baker, D.
    Han, J.
    Xu, W.
    Williamson, P.
    van der Heijde, D.
    RHEUMATOLOGY, 2008, 47 : II72 - II72
  • [48] Sustained reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab
    Braun, Juergen
    Landewe, R.
    Hermann, K. -G.
    Deodhar, A.
    Baker, D.
    Han, J.
    Xu, W.
    Williamson, P.
    van der Heijde, D.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 42 - 42
  • [49] Are Patients with Ankylosing Spondylitis Willing to Pay for Treatment with Infliximab?
    Webers, Casper
    Essers, Ivette
    van Tubergen, Astrid
    Braun, Juergen
    Heldmann, Frank
    Baraliakos, Xenofon
    Boonen, Annelies
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [50] Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
    van der Heijde, Desiree
    Salonen, David
    Weissman, Barbara N.
    Landewe, Robert
    Maksymowych, Walter P.
    Kupper, Hartmut
    Ballal, Shaila
    Gibson, Eric
    Wong, Robert
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (04)
12345